Patents by Inventor Byungwoo Ryu

Byungwoo Ryu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DISPLAY DEVICE AND METHOD FOR CONTROLLING SAME
    Publication number: 20220199006
    Abstract: The present specification discloses a display device which, upon consecutive viewing of images of different frequencies, may improve abnormalities on a screen according to frequency change, and a method for controlling same. A digital device, according to one embodiment of the present invention, comprises: a processor; a display unit comprising a plurality of pixels; and a timing controller for temporally controlling a driving frequency such that the display device is driven, wherein the timing controller controls a light-emitting signal at a preset duty ratio in one frame interval, and when the display unit displays an image of a first input frequency and thereafter displays an image of a second input frequency, a value of a vertical blanking interval for each frame interval gradually changes.
    Type: Application
    Filed: May 31, 2019
    Publication date: June 23, 2022
    Applicant: LG ELECTRONICS INC.
    Inventors: Youngho CHUN, Byungwoo RYU, Hyungil LEE, Joonduck JANG
  • DISPLAY DEVICE
    Publication number: 20210295770
    Abstract: The present disclosure relates to a display device for reducing an input-lag time, capable of detecting an input frequency of a video signal received through an external input interface and adjusting an output frequency of the display panel according to the detected input frequency.
    Type: Application
    Filed: July 24, 2020
    Publication date: September 23, 2021
    Applicant: LG ELECTRONICS INC.
    Inventors: Youngho CHUN, Byungwoo Ryu
  • Assays and methods relating to the treatment of melanoma
    Patent number: 10633712
    Abstract: The technology described herein relates to assays and methods for the diagnosis, prognosis, and/or treatment of melanoma, e.g. relating to measuring the level of neurophilin-2 (NRP-2) mRNA expressed in melanoma cells. In some embodiments, the level of NRP-2 can be normalized to the level of Melan-A (MART) mRNA.
    Type: Grant
    Filed: December 4, 2018
    Date of Patent: April 28, 2020
    Assignee: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Rhoda M. Alani, Byungwoo Ryu
  • ASSAYS AND METHODS RELATING TO THE TREATMENT OF MELANOMA
    Publication number: 20190085411
    Abstract: The technology described herein relates to assays and methods for the diagnosis, prognosis, and/or treatment of melanoma, e.g. relating to measuring the level of neurophilin-2 (NRP-2) mRNA expressed in melanoma cells. In some embodiments, the level of NRP-2 can be normalized to the level of Melan-A (MART) mRNA.
    Type: Application
    Filed: December 4, 2018
    Publication date: March 21, 2019
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Rhoda M. ALANI, Byungwoo RYU
  • Assays and methods relating to the treatment of melanoma
    Patent number: 10174385
    Abstract: The technology described herein relates to assays and methods for the diagnosis, prognosis, and/or treatment of melanoma, e.g. relating to measuring the level of neurophilin-2 (NRP-2) mRNA expressed in melanoma cells. In some embodiments, the level of NRP-2 can be normalized to the level of Melan-A (MART) mRNA.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: January 8, 2019
    Assignee: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Rhoda M. Alani, Byungwoo Ryu
  • ASSAYS AND METHODS RELATING TO THE TREATMENT OF MELANOMA
    Publication number: 20160312300
    Abstract: The technology described herein relates to assays and methods for the diagnosis, prognosis, and/or treatment of melanoma, e.g. relating to measuring the level of neurophilin-2 (NRP-2) mRNA expressed in melanoma cells. In some embodiments, the level of NRP-2 can be normalized to the level of Melan-A (MART) mRNA.
    Type: Application
    Filed: December 19, 2014
    Publication date: October 27, 2016
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Rhoda M. ALANI, Byungwoo RYU
  • Biomarkers for melanoma
    Patent number: 8299216
    Abstract: The present invention relates to methods of determining melanoma status in a subject. The invention also relates to kits for determining melanoma status in a subject. The invention further relates to methods of identifying biomarker for determining melanoma status in a subject.
    Type: Grant
    Filed: July 6, 2007
    Date of Patent: October 30, 2012
    Assignee: The Johns Hopkins University
    Inventors: Rhoda Myra Alani, Byungwoo Ryu
  • Biomarkers for Melanoma
    Publication number: 20080118462
    Abstract: The present invention relates to methods of determining melanoma status in a subject. The invention also relates to kits for determining melanoma status in a subject. The invention further relates to methods of identifying biomarker for determining melanoma status in a subject.
    Type: Application
    Filed: January 9, 2006
    Publication date: May 22, 2008
    Applicant: The John Hopkins University
    Inventors: Rhoda Myra Alani, Byungwoo Ryu